Allegro Development: New White Paper Offers “A Practical Approach to Risk Management”
14.4.2009 18:34:13 CEST | Business Wire | Press release
Allegro Development: New White Paper Offers “A Practical Approach to Risk Management”
A new white paper by risk management authority Dr. Vincent Kaminski explores the growing need for risk management platforms for the energy trading industry, which he says must “reinvent its tool box” to meet the new social and economic forces that continue to shape modern energy markets.
Kaminski, who currently serves as a professor of energy finance and energy derivatives at Rice University’s Jesse H. Jones Graduate School of Management, notes in A Practical Approach to Risk Management that record market volatility, changing regulatory environments and the increasing globalization of the energy marketplace pose “formidable IT challenges to risk management in the energy industry.”
At the root of the need for a universal risk management solution is what Kaminski calls a “skills and knowledge gap” between traders who know the energy markets and regulatory frameworks, analysts who employ highly stylized and abstract systems, and programmers who often have limited industry knowledge and poor communications skills. The challenge companies face is bringing these professionals together and ensuring they work in an effective way. Currently, the critical missing link to accomplishing this goal is a stable and scalable IT platform .
Typically, platforms used for energy trading and risk management have evolved from two types of systems: those used for handling physical flows of commodities, and those for financial systems trading bonds and equities. Specialized modules are then added to support energy trading; however, the end result is often a multiple-platform system that creates major integration issues.
Kaminski suggests that IT teams should evaluate their current IT platforms with an eye to several critical risk management functions:
- A holistic representation of risks;
- Integration of trade processing;
- Integration of downstream systems with corporate systems;
- Efficient links between technology, processes and people.
Historically, risk management has been a low priority in the development and installation of software systems. However, with the pressures and volatility in today’s energy markets, an IT-based solution is critical to avoid potentially major catastrophes.
As Kaminski concludes, “Given what is going to happen in the energy market – the supply and demand pressures, globalization and integration – every company will need efficient risk management. A scalable and stable IT platform and the right combination of people, processes and technology will be critical, not just for performance, but also for survival.”
A Practical Approach to Risk Management is available for download on PDF from the Allegro website .
About Allegro
Allegro is the global leader in energy trading and risk management (ETRM) solutions for producers, refiners, power and gas utilities, commodity traders and commodity consumers. With 25 years of steady growth and deep industry knowledge, our enterprise-wide trading and risk management platform drives transparency and efficiency across front, middle, and back offices, while also managing complex logistics associated with physical commodities. Allegro’s proven solutions provide traders, risk managers and management with flexible solutions - across all currencies and commodity types - that allow decision makers to hedge and execute with confidence. Allegro is headquartered in Dallas, Texas, and serves customers worldwide with offices in Calgary, Houston, London, Rotterdam, Singapore and Zurich, along with a global network of partners.
Members of the media please contact Christie Lindstrom at media@allegrodev.com and for Analyst Inquiries please contact Ray Asif at analysts@allegrodev.com .
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
Contact:
Allegro
Christie Lindstrom, 214-237-8117
media@allegrodev.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
